Filing metadata

Accession number
0001140361-21-018911
Form type
Form 3
Filer
Ernexa Therapeutics Inc.
CIK
CIK 748592
Filed
May 26, 2021
Reporting period
May 06, 2021
Description
Initial ownership

Explore SEC Filings Hub